Is This Biotech Stock After Groundbreaking Approval?
A breakthrough approval can move a biotech stock in dramatic ways. This guide breaks down how to assess the upside, m...
Index levels shift due to earnings, valuations, and macro surprises. Knowing the main drivers helps you anticipate potential reversals.
17,383 articlesA breakthrough approval can move a biotech stock in dramatic ways. This guide breaks down how to assess the upside, m...
Bitcoin profit-taking is picking up as the bear-market rally continues. CryptoQuant reports rising on-chain profits a...
Bitmine Immersion Technologies slows weekly ETH purchases while maintaining a bullish stance. Tom Lee signals a forth...
NextHome opens two Southern California offices, extending its coastal footprint with about 200 agents under a revampe...
Mega-IPOs grab headlines, but what sticks after the first week? This article breaks down the five biggest IPOs in his...
May brings renewed focus on national security and market resilience. This guide identifies a top defense stock and sh...
Investors are focused on figma (FIG) 2026 earnings as the company navigates growth and profitability. This guide brea...
Bitcoin slumped to a two-week low, dragging a wide swath of altcoins lower as risk-off trading returned this weekend....
Bitcoin logged a fresh multi-week low as markets opened, but hype defies altcoin crash with notable gains in HYPE and...
When a legendary investor signals confidence, investors listen. This article delves into why this unstoppable stock s...
Cisco and CrowdStrike rally prompt debate on which name makes the better short bet. The case centers on Cisco's margi...
As inflation cools, a 65-year-old with $7,000 a month must navigate taxes, geography, and housing to determine if ret...